DOW JONES26,957.59-123.77 -0.46%
S&P 5003,116.39-11.82 -0.38%
NASDAQ8,980.78+15.16 0.17%

Enanta Pharmaceuticals Q1 EPS $0.65 Beats $0.58 Estimate, Sales $52.6M Miss $58.86M Estimate

Enanta Pharmaceuticals (NASDAQ:ENTA) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.58 by 12.07 percent. This is a 48 percent decrease over earnings of $1.25 per share from

Benzinga · 02/06/2020 21:00

Enanta Pharmaceuticals (NASDAQ:ENTA) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.58 by 12.07 percent. This is a 48 percent decrease over earnings of $1.25 per share from the same period last year. The company reported quarterly sales of $52.6 million which missed the analyst consensus estimate of $58.86 million by 10.64 percent. This is a 24.73 percent decrease over sales of $69.886 million the same period last year.